Publications by authors named "Paola Ghiorzo"

89Publications

MC1R variants and cutaneous melanoma risk according to histological type, body site, and Breslow thickness: a pooled analysis from the M-SKIP project.

Melanoma Res 2020 Oct;30(5):500-510

aCancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence bMolecular and Pharmaco-Epidemiology Unit, Department of Molecular Oncology, IEO, European Institute of Oncology IRCCS cDepartment of Statistics and Quantitative Methods, Università degli Studi di Milano-Bicocca dDivision of Epidemiology and Biostatistics, IEO, European Institute of Oncology IRCCS eIRCCS MultiMedica, Milan, Italy fDepartment of Dermatology, Instituto Valenciano de Oncologia, Valencia, Spain gSection of Epidemiology and Biostatistics, Institute of Medical Research at St James's, University of Leeds, Leeds, UK hThe Ronald O. Perelman Department of Dermatology, New York University School of Medicine, NYU Langone Medical Center, New York, New York iDivision of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota, USA jDivision of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany kDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA lDepartment of Oncology and Pathology, Cancer Center, Karolinska Institutet, Stockholm, Sweden mDepartment of Internal Medicine and Medical Specialties, University of Genoa and Ospedale Policlinico San Martino, Genoa, Italy nDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland, USA oDpdt. Oncologia medica y hematologia, Fundación Investigación Clínico de Valencia Instituto de Investigación Sanitaria- INCLIVA, Valencia, Spain pImmunology and Diagnostic Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy qAndreas Sygros Hospital, National and Kapodistrian University of Athens, Greece rUnit of Cancer Genetics, Istituto di Chimica Biomolecolare, CNR, Sassari sDepartment of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari 'A. Moro', Bari, Italy tDepartment of Biochemistry, Molecular Biology and Immunology, University of Murcia and IMIB-Arrixaca, Murcia, Spain uDepartment of Epidemiology, Richard M. Fairbanks School of Public Health, Melvin & Bren Simon Cancer Center, Indiana University, Indianapolis, Indiana, USA vSchool of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada wDepartment of Public Health, Environments and Society, London School of Hygiene & Tropical Medicine, London, UK xMelanoma Unit, Dermatology Department, Hospital Clinic Barcelona, Universitat de Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS) Spain & CIBER de Enfermedades Raras, Barcelona, Spain Departments of yDermatology zBiotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000668DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479262PMC
October 2020

Current State of Target Treatment in BRAF Mutated Melanoma.

Front Mol Biosci 2020 14;7:154. Epub 2020 Jul 14.

Medical Oncology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fmolb.2020.00154DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371970PMC
July 2020

Reply to E. Hindié.

J Clin Oncol 2020 Sep 23;38(27):3238-3240. Epub 2020 Jul 23.

Andrea Maurichi, MD, Melanoma and Sarcoma Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Rosalba Miceli, PhD, Medical Statistics, Biometry and Bioinformatics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Hanna Eriksson, MD, PhD, Department of Oncology, Theme Cancer, Karolinska University Hospital, and Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Julia Newton-Bishop, MD, FRCP; Jérémie Nsengimana, PhD; and May Chan, PGD, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom; Andrew J. Hayes, MA, MBBS, MD, PhD and Kara Heelan, MB, BCH, BAO, MRCPI, MD, Sarcoma and Melanoma Units and Skin Unit, The Royal Marsden National Health Service (NHS) Foundation Trust, London, United Kingdom; David Adams, PhD, Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, United Kingdom; Roberto Patuzzo, MD, Melanoma and Sarcoma Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Francesco Barretta, MS, PhD, Medical Statistics, Biometry and Bioinformatics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Gianfranco Gallino, MD, Melanoma and Sarcoma Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Catherine Harwood, MA, MD, PhD, FRCP and Daniele Bergamaschi, PhD, Queen Mary University of London, London, United Kingdom; Dorothy Bennett, FMedSci, PhD, Molecular and Clinical Sciences Research Institute, St George's, University of London, London, United Kingdom; Konstantinos Lasithiotakis, MD, PhD, York Teaching Hospital NHS Foundation Trust, York, United Kingdom and Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Paola Ghiorzo, MD, PhD and Bruna Dalmasso, MD, University Hospital of Genoa, Genoa, Italy; Ausilia Manganoni, MD and Francesca Consoli, MD, University Hospital of Brescia, Brescia, Italy; Ilaria Mattavelli, MD; Consuelo Barbieri, MD; and Andrea Leva, MD, Melanoma and Sarcoma Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Umberto Cortinovis, MD, Plastic and Reconstructive Surgical Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Vittoria Espeli, MD and Cristina Mangas, MD, PhD, Istituto Oncologico Svizzera Italiana, Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland; Pietro Quaglino, MD; Simone Ribero, MD, PhD; and Paolo Broganelli, MD, University Hospital of Turin, Turin, Italy; Giovanni Pellacani, MD, University Hospital of Modena, Modena, Italy; Caterina Longo, MD, Arcispedale S. Maria Nuova, Reggio Emilia, Italy; Corrado Del Forno, MD, University Hospital of Pavia, Pavia, Italy; Lorenzo Borgognoni, MD and Serena Sestini, MD, Ospedale S. Maria Annunziata, Tuscan Cancer Institute, Florence, Italy; Nicola Pimpinelli, MD, PhD and Sara Fortunato, MD, Division of Dermatology, University of Florence, Florence, Italy; Alessandra Chiarugi, MD and Paolo Nardini, MD, Institute for Cancer Research and Prevention, Florence, Italy; Elena Morittu, PhD and Antonio Florita, PhD, Scientific Director's Office, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Mara Cossa, MD, PhD; Barbara Valeri, MD; Massimo Milione, MD, PhD; and Giancarlo Pruneri, MD, Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Odysseas Zoras, MD, PhD, University Hospital of Heraklion, Heraklion, Greece; Andrea Anichini, PhD and Roberta Mortarini, PhD, Immunobiology of Human Cancers Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; and Mario Santinami, MD, Melanoma and Sarcoma Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.20.01460DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499609PMC
September 2020

The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape.

Front Mol Biosci 2020 30;7:113. Epub 2020 Jun 30.

Genetics of Rare Cancers, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fmolb.2020.00113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338720PMC
June 2020

Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility.

Authors:
Maria Teresa Landi D Timothy Bishop Stuart MacGregor Mitchell J Machiela Alexander J Stratigos Paola Ghiorzo Myriam Brossard Donato Calista Jiyeon Choi Maria Concetta Fargnoli Tongwu Zhang Monica Rodolfo Adam J Trower Chiara Menin Jacobo Martinez Andreas Hadjisavvas Lei Song Irene Stefanaki Richard Scolyer Rose Yang Alisa M Goldstein Miriam Potrony Katerina P Kypreou Lorenza Pastorino Paola Queirolo Cristina Pellegrini Laura Cattaneo Matthew Zawistowski Pol Gimenez-Xavier Arantxa Rodriguez Lisa Elefanti Siranoush Manoukian Licia Rivoltini Blair H Smith Maria A Loizidou Laura Del Regno Daniela Massi Mario Mandala Kiarash Khosrotehrani Lars A Akslen Christopher I Amos Per A Andresen Marie-Françoise Avril Esther Azizi H Peter Soyer Veronique Bataille Bruna Dalmasso Lisa M Bowdler Kathryn P Burdon Wei V Chen Veryan Codd Jamie E Craig Tadeusz Dębniak Mario Falchi Shenying Fang Eitan Friedman Sarah Simi Pilar Galan Zaida Garcia-Casado Elizabeth M Gillanders Scott Gordon Adele Green Nelleke A Gruis Johan Hansson Mark Harland Jessica Harris Per Helsing Anjali Henders Marko Hočevar Veronica Höiom David Hunter Christian Ingvar Rajiv Kumar Julie Lang G Mark Lathrop Jeffrey E Lee Xin Li Jan Lubiński Rona M Mackie Maryrose Malt Josep Malvehy Kerrie McAloney Hamida Mohamdi Anders Molven Eric K Moses Rachel E Neale Srdjan Novaković Dale R Nyholt Håkan Olsson Nicholas Orr Lars G Fritsche Joan Anton Puig-Butille Abrar A Qureshi Graham L Radford-Smith Juliette Randerson-Moor Celia Requena Casey Rowe Nilesh J Samani Marianna Sanna Dirk Schadendorf Hans-Joachim Schulze Lisa A Simms Mark Smithers Fengju Song Anthony J Swerdlow Nienke van der Stoep Nicole A Kukutsch Alessia Visconti Leanne Wallace Sarah V Ward Lawrie Wheeler Richard A Sturm Amy Hutchinson Kristine Jones Michael Malasky Aurelie Vogt Weiyin Zhou Karen A Pooley David E Elder Jiali Han Belynda Hicks Nicholas K Hayward Peter A Kanetsky Chad Brummett Grant W Montgomery Catherine M Olsen Caroline Hayward Alison M Dunning Nicholas G Martin Evangelos Evangelou Graham J Mann Georgina Long Paul D P Pharoah Douglas F Easton Jennifer H Barrett Anne E Cust Goncalo Abecasis David L Duffy David C Whiteman Helen Gogas Arcangela De Nicolo Margaret A Tucker Julia A Newton-Bishop Ketty Peris Stephen J Chanock Florence Demenais Kevin M Brown Susana Puig Eduardo Nagore Jianxin Shi Mark M Iles Matthew H Law

Nat Genet 2020 05 27;52(5):494-504. Epub 2020 Apr 27.

Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41588-020-0611-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255059PMC
May 2020

Evolution of approaches to identify melanoma missing heritability.

Expert Rev Mol Diagn 2020 May 14;20(5):523-531. Epub 2020 Mar 14.

Department of Internal Medicine and Medical Specialties, University of Genoa, Genova, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737159.2020.1738221DOI Listing
May 2020

Contribution of Common Genetic Variants to Familial Aggregation of Disease and Implications for Sequencing Studies.

PLoS Genet 2019 11 15;15(11):e1008490. Epub 2019 Nov 15.

Biostatistics Branch: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pgen.1008490DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881075PMC
November 2019

Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.

J Natl Cancer Inst 2018 12;110(12):1328-1341

QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djy171DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292796PMC
December 2018

CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients.

J Am Acad Dermatol 2019 May 28;80(5):1263-1271. Epub 2018 Sep 28.

Department of Internal Medicine and Medical Specialties, University of Genoa and IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01909622183236
Publisher Site
http://dx.doi.org/10.1016/j.jaad.2018.07.060DOI Listing
May 2019

Functional analysis of a CDKN2A 5'UTR germline variant associated with pancreatic cancer development.

PLoS One 2017 7;12(12):e0189123. Epub 2017 Dec 7.

Genetics of Rare Cancers, Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa and Ospedale Policlinico San Martino, Genoa, Italy.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0189123PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720692PMC
December 2017

Identification, genetic testing, and management of hereditary melanoma.

Cancer Metastasis Rev 2017 03;36(1):77-90

Department of Internal Medicine and Medical Specialties, University of Genoa and Genetics of Rare Cancers, IRCCS AOU San Martino-IST, Genoa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10555-017-9661-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385190PMC
March 2017

The Microphthalmia-Associated Transcription Factor p.E318K Mutation Does Not Play a Major Role in Sporadic Renal Cell Tumors from Caucasian Patients.

Pathobiology 2016 22;83(4):165-9. Epub 2016 Mar 22.

Institute of Pathology, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000443311DOI Listing
December 2016

Signs and genetics of rare cancer syndromes with gastroenterological features.

World J Gastroenterol 2015 Aug;21(30):8985-93

William Bruno, Paola Ghiorzo, Genetics of Rare Cancers, Department of Internal Medicine and Medical Specialties, University of Genoa, IRCCS AOU San Martino-IST, 16132 Genoa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v21.i30.8985DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533032PMC
August 2015

Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.

Nat Genet 2015 Sep 3;47(9):987-995. Epub 2015 Aug 3.

Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.3373DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557485PMC
September 2015

BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies.

Onco Targets Ther 2015 16;8:157-68. Epub 2015 Jan 16.

Department of Medical Oncology, IRCCS Azienda Ospedaliera Universitaria San Martino, IST Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S39096DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303458PMC
February 2015

Overcoming resistance to BRAF inhibition in BRAF-mutated metastatic melanoma.

Oncotarget 2014 Nov;5(21):10206-21

Department of Medical Oncology - IRCCS Azienda Ospedaliera Universitaria San Martino - IST - Istituto Nazionale per la Ricerca sul Cancro - Genova, Italy.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279367PMC
http://dx.doi.org/10.18632/oncotarget.2602DOI Listing
November 2014

The effect on melanoma risk of genes previously associated with telomere length.

J Natl Cancer Inst 2014 Oct 17;106(10). Epub 2014 Sep 17.

Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, Leeds Cancer Research UK Centre, University of Leeds, Leeds, UK (MMI, DTB, JCT, MHa, JRM, JANB, JHB); Oncogenomics (NKH), Genetic Epidemiology (NGM), Inflammatory Bowel Diseases Laboratory (GLRS), Cancer Control Group (DCW), Statistical Genetics (SM, MHL), and Molecular Epidemiology (GWM), QIMR Berghofer Medical Research Institute, Brisbane, Australia; INSERM, UMR-946, Genetic Variation and Human Diseases Unit, Paris, France (MB, FD); Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Paris, France (MB, FD); Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney, Australia (AEC); Department of Oncology, University of Cambridge, Cambridge, UK (AMD, PDPP); Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX (JEL); Centre for Genetic Origins of Health and Disease, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia, Crawley, Australia (EKM, SVW); Centre for Cancer Biomarkers CCBIO (LAA) and Gade Laboratory for Pathology (AM), Department of Clinical Medicine, University of Bergen, Bergen, Norway; Department of Pathology, Haukeland University Hospital, Bergen, Norway (LAA); Department of Pathology, Molecular Pathology (PAA) and Department of Dermatology (PH), Oslo University Hospital, Rikshospitalet, Oslo, Norway; Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Service de Dermatologie, Université Paris Descartes, Paris, France (MFA); Department of Dermatology (EA) and Oncogenics Unit (EA, EF), Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv, Israel (EA); Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy (GBS, EFPG); Laboratory of Genetics of Rare Hereditary Cancers, San Martino-IST Research Hospital, Genoa, Italy (GBS, EFPG); Division of Cancer Epidemiology and Gene

View Article

Download full-text PDF

Source
https://genepi.qimr.edu.au/contents/p/staff/IlesMM_JNCI_EPUB
Web Search
http://jnci.oxfordjournals.org/cgi/doi/10.1093/jnci/dju267
Publisher Site
http://dx.doi.org/10.1093/jnci/dju267DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196080PMC
October 2014

Genetic predisposition to pancreatic cancer.

Authors:
Paola Ghiorzo

World J Gastroenterol 2014 Aug;20(31):10778-89

Paola Ghiorzo, Department of Internal Medicine and Medical Specialties, University of Genoa and IRCCS Azienda Ospedaliera Universitaria San Martino-IST Istituto Nazioanle per la Ricerca sul Cancro, 16132 Genoa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v20.i31.10778DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138458PMC
August 2014

A variant in FTO shows association with melanoma risk not due to BMI.

Nat Genet 2013 Apr 3;45(4):428-32, 432e1. Epub 2013 Mar 3.

Section of Epidemiology and Biostatistics, Leeds Institute of Molecular Medicine, Leeds Cancer Research UK Centre, St. James's University Hospital, Leeds, UK.

View Article

Download full-text PDF

Source
https://genepi.qimr.edu.au/contents/p/staff/Iles_etal_Nature
Web Search
http://www.nature.com/doifinder/10.1038/ng.2571
Publisher Site
http://dx.doi.org/10.1038/ng.2571DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640814PMC
April 2013

A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.

Authors:
Corine Bertolotto Fabienne Lesueur Sandy Giuliano Thomas Strub Mahaut de Lichy Karine Bille Philippe Dessen Benoit d'Hayer Hamida Mohamdi Audrey Remenieras Eve Maubec Arnaud de la Fouchardière Vincent Molinié Pierre Vabres Stéphane Dalle Nicolas Poulalhon Tanguy Martin-Denavit Luc Thomas Pascale Andry-Benzaquen Nicolas Dupin Françoise Boitier Annick Rossi Jean-Luc Perrot Bruno Labeille Caroline Robert Bernard Escudier Olivier Caron Laurence Brugières Simon Saule Betty Gardie Sophie Gad Stéphane Richard Jérôme Couturier Bin Tean Teh Paola Ghiorzo Lorenza Pastorino Susana Puig Celia Badenas Hakan Olsson Christian Ingvar Etienne Rouleau Rosette Lidereau Philippe Bahadoran Philippe Vielh Eve Corda Hélène Blanché Diana Zelenika Pilar Galan François Aubin Bertrand Bachollet Céline Becuwe Pascaline Berthet Yves Jean Bignon Valérie Bonadona Jean-Louis Bonafe Marie-Noëlle Bonnet-Dupeyron Fréderic Cambazard Jacqueline Chevrant-Breton Isabelle Coupier Sophie Dalac Liliane Demange Michel d'Incan Catherine Dugast Laurence Faivre Lynda Vincent-Fétita Marion Gauthier-Villars Brigitte Gilbert Florent Grange Jean-Jacques Grob Philippe Humbert Nicolas Janin Pascal Joly Delphine Kerob Christine Lasset Dominique Leroux Julien Levang Jean-Marc Limacher Cristina Livideanu Michel Longy Alain Lortholary Dominique Stoppa-Lyonnet Sandrine Mansard Ludovic Mansuy Karine Marrou Christine Matéus Christine Maugard Nicolas Meyer Catherine Nogues Pierre Souteyrand Laurence Venat-Bouvet Hélène Zattara Valérie Chaudru Gilbert M Lenoir Mark Lathrop Irwin Davidson Marie-Françoise Avril Florence Demenais Robert Ballotti Brigitte Bressac-de Paillerets

Nature 2011 Oct 19;480(7375):94-8. Epub 2011 Oct 19.

1] INSERM, U895 (équipe 1), Equipe labélisée Ligue Contre le Cancer, C3M, 06204 Nice, France [2] Université of Nice Sophia-Antipolis, UFR Médecine, 06204 Nice, France [3] Centre Hospitalier Universitaire de Nice, Service de Dermatologie, 06204 Nice, France [4].

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature10539DOI Listing
October 2011

Genome-wide association study identifies three new melanoma susceptibility loci.

Nat Genet 2011 Oct 9;43(11):1108-13. Epub 2011 Oct 9.

Section of Epidemiology and Biostatistics, Leeds Institute of Molecular Medicine, Leeds Cancer Research UK Centre, St James’s University Hospital, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.959DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251256PMC
October 2011

Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma.

Hum Mol Genet 2010 Apr 21;19(8):1479-91. Epub 2010 Jan 21.

Unit of Molecular Mutagenesis and DNA Repair, National Institute for Cancer Research IST, 16132 Genoa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddq022DOI Listing
April 2010

MDM2 SNP309 genotype influences survival of metastatic but not of localized neuroblastoma.

Pediatr Blood Cancer 2009 Oct;53(4):576-83

Molecular Mutagenesis and DNA Repair Unit, National Cancer Research Institute, Genoa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.22132DOI Listing
October 2009

No evidence for linkage with melanoma in Italian melanoma-prone families.

Cancer Epidemiol Biomarkers Prev 2008 Jul;17(7):1838-40

Division of Cancer Epidemiology and Genetics, Genetic Epidemiology Branch, National Cancer Institute, NIH, Bethesda, MD 20892-7236, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-08-0264DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100360PMC
July 2008

Sex hormone modulation of cell growth and apoptosis of the human monocytic/macrophage cell line.

Arthritis Res Ther 2005 21;7(5):R1124-32. Epub 2005 Jul 21.

Research Laboratory and Division of Rheumatology, Department of Internal Medicine, University of Genova, Italy.

View Article

Download full-text PDF

Source
http://arthritis-research.biomedcentral.com/articles/10.1186
Publisher Site
http://dx.doi.org/10.1186/ar1791DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1257440PMC
April 2006

Genetics of melanoma susceptibility.

Forum (Genova) 2003 ;13(2):114-22; quiz 187

Department of Oncology, Biology and Genetics, University of Genova, Viale Benedetto XV, 6 - 16132 Genova, Italy.

View Article

Download full-text PDF

Source
February 2005